Arkolith/Insider Trading/XERS/Form 4

Pieper Steven

See RemarksXeris Biopharma Holdings, Inc. (XERS) · full profile →Form 4 · filed Jul 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$383K
Net Open-Market Flow
-$383K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 7, 2026Sell(S)28K$8.52$235K1.4M
Jul 6, 2026Sell(S)17K$8.50$148K1.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001875714-26-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML